Edition:
United States

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

0.37USD
13 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.37
Open
$0.24
Day's High
$0.48
Day's Low
$0.24
Volume
671,464
Avg. Vol
43,590
52-wk High
$2.20
52-wk Low
$0.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 5.94 -0.311
Jun '18 7.04 -0.134
Mar '18 7.67 -0.165
FY 2017 Dec '17 7.52 0.325
Sep '17 8.03 -0.029
Jun '17 6.60 -0.140
Mar '17 6.97 -0.507
FY 2016 Dec '16 7.23 -0.147
Sep '16 6.75 -0.227
Jun '16 7.00 -0.277
Mar '16 6.07 -0.388
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 7.75 9.20 6.30 12.61
Quarter Ending Mar-19 2 10.98 11.20 10.77 --
Year Ending Dec-18 2 29.47 31.99 26.94 42.35
Year Ending Dec-19 2 50.16 53.51 46.82 50.09
Earnings (per share)
Quarter Ending Dec-18 2 -0.14 -0.12 -0.16 -0.01
Quarter Ending Mar-19 1 -0.07 -0.07 -0.07 --
Year Ending Dec-18 2 -0.68 -0.58 -0.77 -0.26
Year Ending Dec-19 2 -0.20 -0.11 -0.30 -0.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 38.02 30.88
P/E High - Last 5 Yrs. -- 131.19 46.69
P/E Low - Last 5 Yrs. -- 25.31 25.78
Beta 1.29 0.51 0.95
Price to Sales (TTM) 0.30 5.82 21.76
Price to Book (MRQ) 0.90 4.48 4.53
Price to Tangible Book (MRQ) -- 6.66 11.76
Price to Cash Flow (TTM) -- 17.52 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.07 1.60
Dividend Yield - 5 Year Avg -- 0.86 1.42
Dividend 5 Year Growth Rate -- 7.38 -8.76
Payout Ratio(TTM) -- 44.83 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -26.01 6.45 6.54
Sales (TTM) vs TTM 1 Yr. Ago -2.30 8.26 5.26
Sales - 5 Yr. Growth Rate 46.59 11.87 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago -960.84 15.91 22.50
EPS (TTM) vs TTM 1 Yr. Ago 65.37 -- --
EPS - 5 Yr. Growth Rate -- 4.88 7.64
Capital Spending - 5 Yr. Growth Rate 36.48 11.59 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.74 2.63
Current Ratio (MRQ) 0.46 3.96 3.68
LT Debt to Equity (MRQ) 4.88 43.76 9.53
Total Debt to Equity (MRQ) 128.04 56.24 13.39
Interest Coverage (TTM) -3.15 26.21 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 29.60 39.13 50.91
Gross Margin - 5 Yr. Avg. 31.17 40.26 52.22
EBITD Margin (TTM) -82.55 -- --
EBITD - 5 Yr. Avg -84.63 11.81 16.27
Operating Margin (TTM) -98.40 8.18 -15.11
Operating Margin - 5 Yr. Avg. -92.72 5.79 11.89
Pre-Tax Margin (TTM) -90.95 7.56 -13.67
Pre-Tax Margin - 5 Yr. Avg. -101.25 6.80 12.22
Net Profit Margin (TTM) -33.03 5.14 -17.11
Net Profit Margin - 5 Yr. Avg. -77.65 4.22 8.44
Effective Tax Rate (TTM) -- 21.08 21.73
Effective Tax Rate - 5 Yr. Avg. -- 35.76 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 129,202 9,230,510 878,349,382
Net Income/Employee (TTM) -42,679 -177,571 102,474,711
Receivable Turnover (TTM) 2.27 9.34 5.49
Inventory Turnover (TTM) -- 84.50 3.99
Asset Turnover (TTM) 0.60 0.77 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -19.83 5.72 11.06
Return on Assets - 5 Yr. Avg. -31.53 6.39 11.85
Return on Investment (TTM) -34.57 7.03 13.80
Return on Investment - 5 Yr. Avg. -40.49 8.02 15.17
Return on Equity (TTM) -46.08 0.47 15.29
Return on Equity - 5 Yr. Avg. -50.47 11.50 16.29
  1 Year 3 Year 5 Year
Sales % 7.66 41.87 46.59
EPS (TTM) % 72.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cancer Genetics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 14.83%
# of Holders: 30
Total Shares Held: 4,114,274
3 Mo. Net Change: -21,236
# New Positions: 5
# Closed Positions: 2
# Increased Positions: 12
# Reduced Positions: 9
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.